{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:02:34Z","timestamp":1791428554798,"version":"4.3.3"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The optimal duration of antibiotic therapy for community-acquired pneumonia (CAP) in children remains uncertain. In this study, we aimed to evaluate whether short-course antibiotic therapy (\u22646 days) is associated with poor clinical outcomes compared with long-course antibiotic therapy (&gt;7 days) in children with CAP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A comprehensive search was conducted across databases, including PubMed, Embase, Cochrane Library, and KoreaMed. Studies comparing the efficacy and safety of short-course with long-course antibiotic regimens in children with CAP were eligible. We assessed the risk of bias using the RoB 2 and ROBINS-I tools. Study characteristics such as publication year, country, setting, study design and antibiotic regimens were recorded. Pooled risk ratios (RRs) and 95% confidence intervals (CIs) were calculated for clinical outcomes, including clinical cure, treatment failure, total adverse events, serious adverse events, relapse and hospitalization. The primary outcomes were clinical cure and treatment failure. Secondary outcomes included total and serious adverse events, relapse and hospitalization rates.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Seventeen studies comprising 155,944 children met the inclusion criteria, with 15 of these studies being randomized controlled trials. There were no significant differences between short-course and long-course treatments in clinical cure [21,156 patients; RR, 1.01 (95% CI, 0.97\u20131.05); <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.73; I\u00b2 = 81%], treatment failure [28,942 patients; RR, 0.88 (95% CI, 0.51\u20131.51); <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.64; <jats:italic toggle=\"yes\">I\u00b2<\/jats:italic>= 94%] or total adverse events [24,446 children; RR, 0.94 (95% CI, 0.61\u20131.44); <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.77; <jats:italic toggle=\"yes\">I\u00b2<\/jats:italic> = 90%]. However, short-course treatment was associated with fewer serious adverse events [4194 patients; RR, 0.89 (95% CI, 0.79\u20130.99); <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.04; <jats:italic toggle=\"yes\">I\u00b2<\/jats:italic> = 11%]. Relapse rates were nominally lower with short-course treatment compared with long-course treatments (5.5% vs. 6.2%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.04). This difference was primarily observed in the subgroup analysis comparing 5-day treatments to \u226510-day treatments. Hospitalization rates were similar between the two groups [122,607 patients; RR, 1.20 (95% CI, 0.85\u20131.68); <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.29; <jats:italic toggle=\"yes\">I\u00b2<\/jats:italic> = 0%].<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Short-course antibiotic treatment is as effective as long-course treatment for pediatric CAP in terms of clinical cure and treatment failure while resulting in fewer serious adverse events.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004749","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T14:02:15Z","timestamp":1738591335000},"page":"637-644","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Evaluating Short-course Antibiotic Therapy for Pediatric Community-acquired Pneumonia: A Systematic Review and Meta-analysis"],"prefix":"10.1097","volume":"44","author":[{"given":"Erdenetuya","family":"Bolormaa","sequence":"first","affiliation":[{"name":"Department of Preventive Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho Ryok","family":"Kang","sequence":"additional","affiliation":[{"name":"Allergy and Immunology Center, Korea University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2733-0715","authenticated-orcid":false,"given":"Young June","family":"Choe","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Korea University College of Medicine, Seoul, Republic of Korea"},{"name":"Allergy and Immunology Center, Korea University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"Yoo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Korea University College of Medicine, Seoul, Republic of Korea"},{"name":"Allergy and Immunology Center, Korea University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue Seong","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Korea University College of Medicine, Seoul, Republic of Korea"},{"name":"Allergy and Immunology Center, Korea University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Young","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Korea University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Ah","family":"Choe","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giannoula S.","family":"Tansarli","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Mylonakis","sequence":"additional","affiliation":[{"name":"Department of Medicine, Houston Methodist Hospital, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"R1-20250613","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2471\/BLT.07.048769","article-title":"Epidemiology and etiology of childhood pneumonia.","volume":"86","author":"Rudan","year":"2008","journal-title":"Bull World Health Organ"},{"key":"R2-20250613","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0140-6736(10)60549-1","article-title":"Global, regional, and national causes of child mortality in 2008: a systematic analysis.","volume":"375","author":"Black","year":"2010","journal-title":"Lancet"},{"key":"R3-20250613","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/S2214-109X(18)30408-X","article-title":"Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis.","volume":"7","author":"McAllister","year":"2019","journal-title":"Lancet Glob Health"},{"key":"R4-20250613","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1097\/INF.0b013e3182784b26","article-title":"The burden of childhood pneumonia in the developed world: a review of the literature.","volume":"32","author":"Madhi","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R6-20250613","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R7-20250613","first-page":"Cd008032","article-title":"Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months.","volume":"10","author":"Lassi","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"R8-20250613","first-page":"CD005976","article-title":"Short\u2010course versus long\u2010course antibiotic therapy for non\u2010severe community\u2010acquired pneumonia in children aged 2 months to 59 months.","volume":"2008","author":"Haider","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"R9-20250613","doi-asserted-by":"crossref","first-page":"16","DOI":"10.15172\/pneu.2014.4\/432","article-title":"Evidence for short duration of antibiotic treatment for non-severe community acquired pneumonia (CAP) in children - are we there yet? A systematic review of randomised controlled trials.","volume":"4","author":"Ben-Shimol","year":"2014","journal-title":"Pneumonia (Nathan)"},{"key":"R10-20250613","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R11-20250613","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R12-20250613","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"R13-20250613","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijantimicag.2014.02.016","article-title":"Colistin resistance in Klebsiella pneumoniae.","volume":"44","author":"Ah","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"R14-20250613","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease.","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"R15-20250613","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials.","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R16-20250613","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jpeds.2021.03.017","article-title":"Short- versus prolonged-duration antibiotics for outpatient pneumonia in children.","volume":"234","author":"Shapiro","year":"2021","journal-title":"J Pediatr"},{"key":"R17-20250613","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/jpids\/piaa055","article-title":"The association of antibiotic duration with successful treatment of community-acquired pneumonia in children.","volume":"10","author":"Same","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R18-20250613","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0140-6736(02)09994-4","article-title":"Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial.","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"R19-20250613","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/bmj.38049.490255.DE","article-title":"Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial.","volume":"328","author":"Agarwal","year":"2004","journal-title":"BMJ"},{"key":"R20-20250613","doi-asserted-by":"crossref","first-page":"04097","DOI":"10.7189\/jogh.12.04097","article-title":"Community case management of fast-breathing pneumonia with 3 days oral amoxicillin vs 5 days cotrimoxazole in children 2-59 months of age in rural Pakistan: a cluster randomized trial.","volume":"12","author":"Ahmed","year":"2022","journal-title":"J Glob Health"},{"key":"R21-20250613","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/tropej\/fmn050","article-title":"Effectiveness of 3-day amoxycillin vs. 5-day co-trimoxazole in the treatment of non-severe pneumonia in children aged 2\u201359 months of age: a multi-centric open labeled trial.","volume":"54","author":"Awasthi","year":"2008","journal-title":"J Trop Pediatr"},{"key":"R22-20250613","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1001\/jama.2021.17843","article-title":"Effect of amoxicillin dose and treatment duration on the need for antibiotic re-treatment in children with community-acquired pneumonia: the CAP-IT randomized clinical trial.","volume":"326","author":"Bielicki","year":"2021","journal-title":"JAMA"},{"key":"R23-20250613","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/jamapediatrics.2020.6735","article-title":"Short-course antimicrobial therapy for pediatric community-acquired pneumonia: the safer randomized clinical trial.","volume":"175","author":"Pernica","year":"2021","journal-title":"JAMA Pediatr"},{"key":"R24-20250613","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1912400","article-title":"Amoxicillin for 3 or 5 days for chest-indrawing pneumonia in Malawian children.","volume":"383","author":"Ginsburg","year":"2020","journal-title":"N Engl J Med"},{"key":"R25-20250613","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/INF.0000000000000023","article-title":"Short-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial.","volume":"33","author":"Greenberg","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R26-20250613","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1001\/jamapediatrics.2021.5547","article-title":"Short- vs standard-course outpatient antibiotic therapy for community-acquired pneumonia in children: the SCOUT-CAP randomized clinical trial.","volume":"176","author":"Williams","year":"2022","journal-title":"JAMA Pediatr"},{"key":"R27-20250613","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/cid\/ciy918","article-title":"Comparison of 3 days amoxicillin versus 5 days co-trimoxazole for treatment of fast-breathing pneumonia by community health workers in children aged 2-59 months in Pakistan: a cluster-randomized trial.","volume":"69","author":"Sadruddin","year":"2019","journal-title":"Clin Infect Dis"},{"key":"R28-20250613","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/00006454-199810000-00004","article-title":"Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children.","volume":"17","author":"Harris","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"R29-20250613","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.10180","article-title":"Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.","volume":"35","author":"Kogan","year":"2003","journal-title":"Pediatr Pulmonol"},{"key":"R30-20250613","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0011-393X(05)80588-0","article-title":"The role of azithromycin in treating children with community-acquired pneumonia.","volume":"55","author":"Ronchetti","year":"1994","journal-title":"Curr Ther Res"},{"key":"R31-20250613","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00006454-199902000-00004","article-title":"Etiology and treatment of community-acquired pneumonia in ambulatory children.","volume":"18","author":"Wubbel","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"R32-20250613","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/INF.0000000000003558","article-title":"Extended versus standard antibiotic course duration in children <5 years of age hospitalized with community-acquired pneumonia in high-risk settings: four-week outcomes of a multicenter, double-blind, parallel, superiority randomized controlled trial.","volume":"41","author":"McCallum","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"R33-20250613","doi-asserted-by":"crossref","first-page":"e1123","DOI":"10.1093\/cid\/ciac374","article-title":"Antibiotic treatment duration for community-acquired pneumonia in outpatient children in high-income countries\u2014a systematic review and meta-analysis.","volume":"76","author":"Kuitunen","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R34-20250613","doi-asserted-by":"crossref","first-page":"e2022060097","DOI":"10.1542\/peds.2022-060097","article-title":"Shorter versus longer-term antibiotic treatments for community-acquired pneumonia in children: a meta-analysis.","volume":"151","author":"Gao","year":"2023","journal-title":"Pediatrics"},{"key":"R35-20250613","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/cid\/ciae302","article-title":"The Use of Long-term Antibiotics for Suppression of Bacterial Infections.","volume":"79","author":"Horne","year":"2024","journal-title":"Clin Infect Dis"},{"key":"R36-20250613","doi-asserted-by":"crossref","first-page":"e2253806","DOI":"10.1001\/jamanetworkopen.2022.53806","article-title":"Association Between Antimicrobial Stewardship Programs and Antibiotic Use Globally: A Systematic Review and Meta-Analysis.","volume":"6","author":"Zay Ya","year":"2023","journal-title":"JAMA Netw Open"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T22:03:44Z","timestamp":1749852224000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004749","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]}}}